- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Pharmacokinetic Studies of Orally Administered Magnesium Oxide in Rats
-
- Yoshimura Yuya
- Pharmaceutical Information Section, Medical Seals Division, Kyowa Chemical Industry, Co., Ltd.
-
- Fujisaki Kosuke
- Pharmaceutical Information Section, Medical Seals Division, Kyowa Chemical Industry, Co., Ltd.
-
- Yamamoto Takenori
- Institute for Genome Research, University of Tokushima Faculty of Pharmaceutical Science, University of Tokushima
-
- Shinohara Yasuo
- Institute for Genome Research, University of Tokushima Faculty of Pharmaceutical Science, University of Tokushima
Bibliographic Information
- Other Title
-
- 酸化マグネシウム製剤を経口投与したラットでのマグネシウムの動態解析
- サンカ マグネシウム セイザイ オ ケイコウ トウヨ シタ ラット デ ノ マグネシウム ノ ドウタイ カイセキ
Search this article
Description
Magnesium oxide (MgO) tablets are widely used as laxatives in patients with constipation. Recently, the “Revision of Precautions on the Use of Magnesium Oxide” has been issued by the Japanese Pharmaceuticals and Medical Devices Agency, warning against the risk of hypermagnesemia with the use of MgO. However, the majority of physicians continue to administer MgO for constipation without adequately considering its safe use. In the present study, we performed two analyses using an identical lot of MgO tablets and evaluated the risk of hypermagnesemia. Approximately 90% of the MgO tablets dissolved within 120 min in dissolution testing; it was believed to form an absorbable state for magnesium. With orally administered MgO, 15% is absorbed in the body and 85% is excreted via the feces without being detected in pharmacokinetic analysis. Magnesium absorbed into the plasma demonstrated peak concentration 3 h after administration and was excreted via the urine within 48 h.<br>
Journal
-
- YAKUGAKU ZASSHI
-
YAKUGAKU ZASSHI 137 (5), 581-587, 2017-05-01
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390282681193399936
-
- NII Article ID
- 130005631456
-
- NII Book ID
- AN00284903
-
- ISSN
- 13475231
- 00316903
-
- NDL BIB ID
- 028198850
-
- PubMed
- 28123145
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
- KAKEN
- OpenAIRE
-
- Abstract License Flag
- Disallowed